drugset / Trial / NCT01331304

Comparative Effectiveness Study for Bipolar Disorder

NCT01331304

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to compare the effectiveness of lithium and quetiapine for the treatment of individuals with bipolar disorder.

Timeline

Start
2010-09
Primary completion
2013-04
Completion
2013-09

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Lithium Unknown 600 mg
Subject Lithium Unknown 900 mg
Subject Quetiapine Small molecule 100 mg
Subject Quetiapine Small molecule 800 mg

Indications